Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

homeHome
play_circleCurrent Issuecheck_circleAccepted ManuscriptslistAll Issuesformat_indent_increaseIn Press ArticlessearchSearch
helpInstructions
infoJournal InformationgroupsBoards and committeesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementmenu_bookReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Virological surveillance, molecular phylogeny, and evolutionary dynamics of hepatitis C virus subtypes 1a and 4a isolates in patients from Saudi Arabia

- AlMalki W.H. , et al.

2. Hepatitis C virus infection in southwestern Saudi Arabia: Are we still in the plateau phase?

- Al Humayed S.M. , et al.

3. Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia

- El Hadad S. , et al.

4. Epidemiology and clinical features of patients with hepatocellular carcinoma at a tertiary hospital in Jeddah

- Qari Y.A. , et al.

5. The distribution of hepatitis C virus genotypes in middle eastern countries: A systematic review and meta-analysis

- Ghaderi-Zefrehi H. , et al.

6. Prevalence of hepatitis C virus genotypes among patients in countries of the eastern mediterranean regional office of WHO (EMRO): A systematic review and meta-analysis

- Sadeghi F. , et al.

7. Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: A meta-Analysis

- Yee B.E. , et al.

8. Predicting the outcomes of combination therapy in patients with chronic hepatitis c using artificial neural network

- Aval F.S. , et al.

9. Meta-analysis: Influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin

- Yee B.E. , et al.